Delivery Method: UPS Product: Drugs Recipient: Recipient Name Mr. Arun Kumar Recipient Title Chief Executive Officer/Managing Director Strides Pharma Science Limited Strides House, BilekahalliBannerghatta RoadBangalore 560076India […]

FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use Health Care Professionals; Patients; Podcasts Drug Development; Drug Regulatory Process; […]

A Sunscreen Message for Consumers (2:35) What’s New FDA regulates sunscreens to ensure they meet safety and effectiveness standards. To improve the quality, safety, and effectiveness […]

FDA’s Drug Supply Chain Security Act (DSCSA) Pilot Project Program was established to assist drug supply chain stakeholders, including FDA, with developing electronic, interoperable capabilities that […]

Submit Comments by 07/23/2023 Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment […]

For Immediate Release: May 23, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, […]

For Immediate Release: May 23, 2023 Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat […]

English La FDA está alertando a los consumidores y a las farmacias de que no utilicen ni vendan un lote específico de G-Supress DX Pediatric Drops […]

Product: Drugs Recipient: Firsttrustchemicals.com United States Issuing Office: United States TO:        Firsttrustchemicals.com FROM:        The United States Food and Drug Administration RE:        Notice of Unlawful Sale of […]